Evidence map›Paper›PMID 36979420›Full record

ReviewBiomolecules2023

Distinct Roles of SELENOF in Different Human Cancers.

Brenna Flowers, Oliwia Bochnacka, Allison Poles, Alan M Diamond, Irida Kastrati

Open access · goldFull text readReview
In one paragraph

Review in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Selenium-Containing Compounds in Breast Cancer Therapy.Biological trace element research · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Animals : an open access journal from MDPI · 2026
    Article
  6. Review
  7. Selenium in Surgery.Cureus · 2024
    Review
  8. Deciphering the Role of Selenoprotein M.Antioxidants (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Brenna FlowersDepartment of Cancer Biology, Loyola University Chicago, Maywood, IL 60153, USA.
Oliwia BochnackaDepartment of Cancer Biology, Loyola University Chicago, Maywood, IL 60153, USA.
Allison PolesDepartment of Cancer Biology, Loyola University Chicago, Maywood, IL 60153, USA.ORCID 0000-0002-1225-7546
Alan M DiamondDepartment of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0001-6032-1293
Irida KastratiDepartment of Cancer Biology, Loyola University Chicago, Maywood, IL 60153, USA.ORCID 0000-0002-8086-1411
Loyola University Chicago · USUniversity of Illinois Chicago · US

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
NIEHS NIH HHS P30 ES027792
6 · The paper itself

Abstract

SELENOF, previously known as SEP15, is a selenoprotein that contains selenium in the form of the amino acid selenocysteine. Like other selenoproteins, the role for SELENOF in carcinogenesis has been investigated due to its altered expression compared to the corresponding normal tissue, its molecular function, and the association of genetic variations in the

Indexed as

NeoplasmsSeleniumFemaleHumansMaleOxidation-ReductionProstateSelenoproteinsSeleniumSELENOF protein, humanSelenoproteinscancerenergy metabolismredox protein quality controlSELENOFselenoprotein F

Identifiers

PMID36979420
PMCPMC10046285
OpenAlexW4323312944

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read6
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.